UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatment

Clinical cancer research, 2015-04, Vol.21 (8), p.1789-1794

2015

Volltextzugriff (PDF)

Cbl interacts with multiple E2s in vitro and in cells

PloS one, 2019-05, Vol.14 (5), p.e0216967-e0216967

2019

Volltextzugriff (PDF)

Reaction of human albumin with aspirin in vitro: Mass spectrometric identification of acetylated lysines 199, 402, 519, and 545

Biochemical pharmacology, 2010-03, Vol.79 (5), p.784-791

2010

Volltextzugriff (PDF)

Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth

The Journal of biological chemistry, 2023-01, Vol.299 (1), p.102766, Article 102766

2023

Volltextzugriff (PDF)

Cresyl Saligenin Phosphate, an Organophosphorus Toxicant, Makes Covalent Adducts with Histidine, Lysine, and Tyrosine Residues of Human Serum Albumin

Chemical research in toxicology, 2012-08, Vol.25 (8), p.1752-1761

2012

Volltextzugriff (PDF)

Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells

Molecular pharmaceutics, 2017-04, Vol.14 (4), p.1047-1056

2017

Volltextzugriff (PDF)

Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesterase

Chemico-biological interactions, 2013-03, Vol.203 (1), p.103-107

2013

Volltextzugriff (PDF)

Newly Observed Spontaneous Activation of Ethephon as a Butyrylcholinesterase Inhibitor

Chemical research in toxicology, 2013-03, Vol.26 (3), p.422-431

2013

Volltextzugriff (PDF)

Mass Spectrometry Provides a Highly Sensitive Noninvasive Means of Sequencing and Tracking M‑Protein in the Blood of Multiple Myeloma Patients

Journal of proteome research, 2021-08, Vol.20 (8), p.4176-4185

2021

Volltextzugriff (PDF)

Abstract 3031: Bufalin regulates Cbl-b levels in HeLa cells through protein synthesis inhibition

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3031-3031

2016

Volltextzugriff (PDF)

Novel Assay for Quantification of Free Light Chain (FLC) Dimers in Serum of Patients with Plasma Cell Dyscrasias

Blood, 2023-11, Vol.142 (Supplement 1), p.2292-2292

2023

Volltextzugriff (PDF)

Abstract 2506: Flotillin 2 negatively regulates EGFR phosphorylation and Cbl-mediated ubiquitination and degradation

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2506-2506

2018

Volltextzugriff (PDF)

Measurable Residual Disease Status By Clonotypic Mass Spectrometry with Easym Assay Predicts Outcomes Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma

Blood, 2023-11, Vol.142 (Supplement 1), p.3354-3354

2023

Volltextzugriff (PDF)

Abstract 117: Elucidating the role of Flotillin-2 in EGFR signaling and cancer growth

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.117-117

2020

Volltextzugriff (PDF)

M-Protein Sequencing and Monitoring in Serum of LC-Only Multiple Myeloma Patients

Blood, 2021-11, Vol.138 (Supplement 1), p.4729-4729

2021

Volltextzugriff (PDF)

Clonotypic Mass Spectrometry with Easym Assay for Detection of Measurable Residual Disease in Multiple Myeloma

Blood, 2022-11, Vol.140 (Supplement 1), p.4376-4377

2022

Volltextzugriff (PDF)

A Personalized Mass Spectrometry-Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM)

Clinical cancer research, 2021-09, Vol.27 (18), p.5028-5037

2021

Volltextzugriff (PDF)

Targeted Mass Spectrometry-Based Serum M-Protein Monitoring for Early Relapse Detection

Blood, 2019-11, Vol.134 (Supplement_1), p.4347-4347

2019

Volltextzugriff (PDF)

Abstract 555: Loss of function Cbl-c mutations in solid tumors

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.555-555

2018

Volltextzugriff (PDF)

Abstract 4441: Ube2e inhibits the ubiquitination and degradation of EGFR mediated by Cbl and Ube2d

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4441-4441

2014

Volltextzugriff (PDF)

P-085 The use of clonotypic mass spectrometry for post-AHCT blood-based measurable residual disease monitoring in patients with light chain multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S81-S82

2023

Volltextzugriff (PDF)

Exposure to tri- o-cresyl phosphate detected in jet airplane passengers

Toxicology and applied pharmacology, 2011-11, Vol.256 (3), p.337-347

2011

Volltextzugriff (PDF)

Exposure to tri-o-cresyl phosphate detected in jet airplane passengers : Environmental chemicals and neurotoxicity

Toxicology and applied pharmacology, 2011, Vol.256 (3), p.337-347

2011

Volltextzugriff (PDF)

Exposure to tri-ortho-cresyl phosphate as a possible explanation of “aerotoxic syndrome”

Liyasova, Mariya Sergeyevna

2012

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)
Dissertationen
(1)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatment

Cbl interacts with multiple E2s in vitro and in cells

Reaction of human albumin with aspirin in vitro: Mass spectrometric identification of acetylated lysines 199, 402, 519, and 545

Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth

Cresyl Saligenin Phosphate, an Organophosphorus Toxicant, Makes Covalent Adducts with Histidine, Lysine, and Tyrosine Residues of Human Serum Albumin

Engineered Multivalency Enhances Affibody-Based HER3 Inhibition and Downregulation in Cancer Cells

Cresyl saligenin phosphate makes multiple adducts on free histidine, but does not form an adduct on histidine 438 of human butyrylcholinesterase

Newly Observed Spontaneous Activation of Ethephon as a Butyrylcholinesterase Inhibitor

Mass Spectrometry Provides a Highly Sensitive Noninvasive Means of Sequencing and Tracking M‑Protein in the Blood of Multiple Myeloma Patients

Abstract 3031: Bufalin regulates Cbl-b levels in HeLa cells through protein synthesis inhibition

Novel Assay for Quantification of Free Light Chain (FLC) Dimers in Serum of Patients with Plasma Cell Dyscrasias

Abstract 2506: Flotillin 2 negatively regulates EGFR phosphorylation and Cbl-mediated ubiquitination and degradation

Measurable Residual Disease Status By Clonotypic Mass Spectrometry with Easym Assay Predicts Outcomes Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma

Abstract 117: Elucidating the role of Flotillin-2 in EGFR signaling and cancer growth

M-Protein Sequencing and Monitoring in Serum of LC-Only Multiple Myeloma Patients

Clonotypic Mass Spectrometry with Easym Assay for Detection of Measurable Residual Disease in Multiple Myeloma

A Personalized Mass Spectrometry-Based Assay to Monitor M-Protein in Patients with Multiple Myeloma (EasyM)

Targeted Mass Spectrometry-Based Serum M-Protein Monitoring for Early Relapse Detection

Abstract 555: Loss of function Cbl-c mutations in solid tumors

Abstract 4441: Ube2e inhibits the ubiquitination and degradation of EGFR mediated by Cbl and Ube2d

P-085 The use of clonotypic mass spectrometry for post-AHCT blood-based measurable residual disease monitoring in patients with light chain multiple myeloma

Exposure to tri- o-cresyl phosphate detected in jet airplane passengers

Exposure to tri-o-cresyl phosphate detected in jet airplane passengers : Environmental chemicals and neurotoxicity

Exposure to tri-ortho-cresyl phosphate as a possible explanation of “aerotoxic syndrome”

Suchergebnisse filtern